Haematologica

Keyphrases

Publications

volume 108, number 12, 2023

Henry S Ngu, Kerry J Savage
Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas. Haematologica 108 (12) (2023)
Bettina Bisig, Kerry J Savage, Laurence De Leval
Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions. Haematologica 108 (12) (2023)
Kerry J Savage, Laurence De Leval
Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization. Haematologica 108 (12) (2023)
Robert Stuver, Zachary D Epstein-Peterson, Steven M Horwitz
Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas. Haematologica 108 (12) (2023)
Natasha E Lewis, Ting Zhou, Ahmet Dogan
Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders. Haematologica 108 (12) (2023)

volume 108, number 2, 2023

Victoria Y Ling, Steven W Lane
t(15;17) in acute promyelocytc leukemia. Haematologica 108 (2) (2023)
Richard F Schlenk
Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges. Haematologica 108 (2) (2023)
Estefanía García-Guerrero, Luis G Rodríguez-Lobato, Belén Sierro-Martínez, Sophia Danhof, Stephan Bates, Silke Frenz, Larissa Härtle, Ralph Götz, Markus Sauer, Leo Rasche, K Martin Kortüm, Jose A Pérez-Simón, Hermann Einsele, Michael Hudecek, Sabrina R Prommersberger
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells. Haematologica 108 (2) (2023)
Razan Mohty, Rama El Hamed, Eolia Brissot, Ali Bazarbachi, Mohamad Mohty
New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia. Haematologica 108 (2) (2023)
Razan Mohty, Rama El Hamed, Eolia Brissot, Ali Bazarbachi, Mohamad Mohty
New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia. Haematologica 108 (2) (2023)
Victoria Y Ling, Steven W Lane
t(15;17) in acute promyelocytc leukemia. Haematologica 108 (2) (2023)
Sabine Kayser, Mark J Levis
The clinical impact of the molecular landscape of acute myeloid leukemia. Haematologica 108 (2) (2023)
Sonia Jaramillo, Richard F Schlenk
Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question. Haematologica 108 (2) (2023)
Richard F Schlenk
Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges. Haematologica 108 (2) (2023)
Sabine Kayser, Mark J Levis
The clinical impact of the molecular landscape of acute myeloid leukemia. Haematologica 108 (2) (2023)
Razan Mohty, Rama El Hamed, Eolia Brissot, Ali Bazarbachi, Mohamad Mohty
New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia. Haematologica 108 (2) (2023)
Estefanía García-Guerrero, Luis G Rodríguez-Lobato, Belén Sierro-Martínez, Sophia Danhof, Stephan Bates, Silke Frenz, Larissa Haertle, Ralph Götz, Markus Sauer, Leo Rasche, K Martin Kortüm, Jose A Pérez-Simón, Hermann Einsele, Michael Hudecek, Sabrina R Prommersberger
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells. Haematologica 108 (2) (2023)
Patrick Stelmach, Andreas Trumpp
Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica 108 (2) (2023)
Sonia Jaramillo, Richard F Schlenk
Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question. Haematologica 108 (2) (2023)
Patrick Stelmach, Andreas Trumpp
Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica 108 (2) (2023)
Sabine Kayser, Mark J Levis
The clinical impact of the molecular landscape of acute myeloid leukemia. Haematologica 108 (2) (2023)
Richard F Schlenk
Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges. Haematologica 108 (2) (2023)
Estefanía García-Guerrero, Luis G Rodríguez-Lobato, Belén Sierro-Martínez, Sophia Danhof, Stephan Bates, Silke Frenz, Larissa Härtle, Ralph Götz, Markus Sauer, Leo Rasche, K Martin Kortüm, Jose A Pérez-Simón, Hermann Einsele, Michael Hudecek, Sabrina R Prommersberger
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells. Haematologica 108 (2) (2023)
Victoria Y Ling, Steven W Lane
t(15;17) in acute promyelocytc leukemia. Haematologica 108 (2) (2023)
Patrick Stelmach, Andreas Trumpp
Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica 108 (2) (2023)
Victoria Y Ling, Steven W Lane
t(15;17) in acute promyelocytc leukemia. Haematologica 108 (2) (2023)
Sonia Jaramillo, Richard F Schlenk
Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question. Haematologica 108 (2) (2023)
Estefanía García-Guerrero, Luis G Rodríguez-Lobato, Belén Sierro-Martínez, Sophia Danhof, Stephan Bates, Silke Frenz, Larissa Haertle, Ralph Götz, Markus Sauer, Leo Rasche, K Martin Kortüm, Jose A Pérez-Simón, Hermann Einsele, Michael Hudecek, Sabrina R Prommersberger
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells. Haematologica 108 (2) (2023)
Richard F Schlenk
Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges. Haematologica 108 (2) (2023)
Patrick Stelmach, Andreas Trumpp
Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica 108 (2) (2023)
Razan Mohty, Rama El Hamed, Eolia Brissot, Ali Bazarbachi, Mohamad Mohty
New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia. Haematologica 108 (2) (2023)
Estefanía García-Guerrero, Luis G Rodríguez-Lobato, Belén Sierro-Martínez, Sophia Danhof, Stephan Bates, Silke Frenz, Larissa Haertle, Ralph Götz, Markus Sauer, Leo Rasche, K Martin Kortüm, Jose A Pérez-Simón, Hermann Einsele, Michael Hudecek, Sabrina R Prommersberger
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells. Haematologica 108 (2) (2023)
Sonia Jaramillo, Richard F Schlenk
Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question. Haematologica 108 (2) (2023)
Sabine Kayser, Mark J Levis
The clinical impact of the molecular landscape of acute myeloid leukemia. Haematologica 108 (2) (2023)
Estefanía García-Guerrero, Luis G Rodríguez-Lobato, Belén Sierro-Martínez, Sophia Danhof, Stephan Bates, Silke Frenz, Larissa Haertle, Ralph Götz, Markus Sauer, Leo Rasche, K Martin Kortüm, Jose A Pérez-Simón, Hermann Einsele, Michael Hudecek, Sabrina R Prommersberger
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells. Haematologica 108 (2) (2023)

volume 108, number 3, 2023

Corey Cutler
The development of graft- versus -host disease prophylaxis. Haematologica 108 (3) (2023)
Corey Cutler
The development of graft- versus -host disease prophylaxis. Haematologica 108 (3) (2023)
Corey Cutler
The development of graft- versus -host disease prophylaxis. Haematologica 108 (3) (2023)
Corey Cutler
The development of graft- versus -host disease prophylaxis. Haematologica 108 (3) (2023)

volume 108, number 4, 2023

Alan T Nurden
The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia. Haematologica 108 (4) (2023)
Alan T Nurden
The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia. Haematologica 108 (4) (2023)

volume 108, number 5, 2023

Pier Mannuccio Mannucci
Recombinant FVIII: the milestone of modern hemophilia treatment. Haematologica 108 (5) (2023)
Pier Mannuccio Mannucci
Recombinant FVIII: the milestone of modern hemophilia treatment. Haematologica 108 (5) (2023)
Pier Mannuccio Mannucci
Recombinant FVIII: the milestone of modern hemophilia treatment. Haematologica 108 (5) (2023)

volume 108, number 6, 2023

Ann S LaCasce
The International Prognostic Index: still relevant 30 years later. Haematologica 108 (6) (2023)

volume 108, number 7, 2023

Sarah K Tasian
TCF3::HLF acute lymphoblastic leukemia: still challenging to cure thirty years later. Haematologica 108 (7) (2023)
Sarah K Tasian
TCF3::HLF acute lymphoblastic leukemia: still challenging to cure thirty years later. Haematologica 108 (7) (2023)
Sarah K Tasian
TCF3::HLF acute lymphoblastic leukemia: still challenging to cure thirty years later. Haematologica 108 (7) (2023)

volume 108, number 8, 2023

Yishai Ofran
Chasing quality remission in acute myeloid leukemia: intensity of induction and residual disease. Haematologica 108 (8) (2023)

volume 108, number 9, 2023

Sonali M Smith
When more is just more, not better: a recurring lesson. Haematologica 108 (9) (2023)